InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: ash111 post# 40474

Sunday, 10/22/2017 10:38:11 AM

Sunday, October 22, 2017 10:38:11 AM

Post# of 48316
Ash, those Maxim calculations are very conservative and assume only a fraction of the 10,000 potential patients for melanoma and a 2021 approval timeline. I think we get an accelerated approval on good numbers next year. I also think that Oncosec tapped the ATM with the recent share spikes. Leading up to the SITC full data release we are likely to see more of the same price action. If they announce that they have executed the ATM fully already that would set us up nicely for the SITC news. We know the numbers are better than expected, but when we see the actual data and charts that explain fully that more partial responders are becoming complete responders at 24 weeks Oncosec stock will move higher and maintain a higher share price. I expect that Adam F. will like the data also and have a nice writeup on Oncosec shortly after SITC.